NFKB1 and colorectal carcinoma: The PXR induced by Trp metabolites suppresses the action of MPO and pro-inflammatory cytokines such as NF-κB, TNF-α, which can modulate gut immunological, inflammation, and barrier functions, hence reducing the development of CRC (125) (Figure 3).